Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Radiotherapy for Non-Malignant Disorders, Hardback Book

Radiotherapy for Non-Malignant Disorders Hardback

Edited by Michael Heinrich Seegenschmiedt, Hans-Bruno Makoski, Klaus-Rudiger Trott, Luther W. Brady

Part of the Radiation Oncology series

Hardback

Description

Non-malignant, or "benign", diseases can be successfully treated using ionizing rad- tion technologies.

It was first proposed in 1898 by Sokoloff, who reported the analgesic effects of radiotherapy for painful rheumatoid arthritis.

Since then, the use of these techniques for painful muscle-skeletal diseases has gained acceptance particularly in Europe but is still carried out actively in the United States.

Non-malignant diseases that are amenable to radiotherapy can be classified as inflammatory, degenerative, hype- roliferative, functional, or other disorders.

However, the topographic and morphologic considerations are more relevant.

Even though radiation therapy for "benign" diseases has not been pursued actively since the 1950s, more recent interest has dictated that it can be a very effective treatment modality.

The use of radiotherapy can be justified for invasive and aggressive growth such as that seen with desmoids, for cosmetic d- figurations and functional loss as seen with keloids or endocrine orbitopathy, or for life-threatening complications such as hepatic hemangiomas or juvenile angiofibromas that occur in children or adolescents.

Many of the non-malignant diseases can have a major and lasting effect on quality of life by causing pain or other serious symptoms, particularly when other methods of treatment are unavailable, have failed, or may induce more side effects.

It is not generally the first choice of therapy in these non-malignant diseases, but it is acceptable as defined.

The book edited by Seegenschmiedt et al.

Information

Save 4%

£249.99

£239.99

 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information